Published June 30, 2025 | Version 1.0
Journal Open

Epidemiological Patterns of Genotype Distribution among Hepatitis C Patients in India: A Narrative Review

Authors/Creators

  • 1. Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab

Contributors

  • 1. Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab

Description

Different genotypes of Hepatitis C have different epidemiological and clinical features, showing varying prognostic implications. This review captures the genotype distribution among Hepatitis C patients in India. The most predominant Hepatitis C virus genotype in India is GT3, followed by GT1, which is also significantly prevalent. GT4 and GT6 are increasingly prevalent in southern and north-eastern parts of India, respectively. Other rare genotypes such as GT2, GT5, and GT8 have also been reported across various parts of India. Among the primary modes of HCV transmission, intravenous drug use is more common in the younger population, while haemodialysis-related transmission is more prevalent among elderly males. HCV GT3 and GT1 appear to have a strong association with the patients being infected through intravenous drug abuse and haemodialysis, respectively.

Files

15_PAID_798_REVIEW_Parmil Tiwari__IJPSM_Vol.56 [2]_293-300.pdf

Files (314.2 kB)

Additional details

Dates

Available
2025-06-30

References

  • 1. Daw MA, El-Bouzedi AA, Ahmed MO, Dau AA, Agnan MM, Drah AM. Geographic integration of hepatitis C virus: A global threat. World Journal of Virology. 2016; 5(4):170-82.
  • 2. Mahmud S, Chemaitelly HS, Kouyoumjian SP, Al Kanaani Z, Abu-Raddad LJ. Key associations for hepatitis C virus genotypes in the Middle East and North Africa. Journal of Medical Virology. 2020; 92(3):386-93.
  • 3. Shahanas SM, Verma R, Kumar K, Verma M, Srivastavsa DC, Budhwani P. A Study on the Prevalence of HCV Genotypes and the Effect of Direct-Acting Antiviral Therapy on Clinical and Laboratory Parameters in HCV-Infected Patients at a Tertiary Care Center in North India. Indian Journal of Community Medicine. 2024; 49(1).
  • 4. Martinez MA, Franco S. Therapy Implications of Hepatitis C Virus Genetic Diversity. Viruses [Internet]. 2021; 13(1).
  • 5. Chandra M, Ahmad Paray A, Arora K. Prevalence of hepatitis C virus infection in India: a systematic review. International Journal of Research in Medical Sciences. 2024; 12 (7):2529-36.
  • 6. Tahashildar M, Rao MR, Hani U, Shivappa SG, Mahale RP, Kumar R. Distribution of HCV genotypes among patients attending south Indian tertiary care centre. Journal of Krishna Institute of Medical Sciences University. 2023; 12 (2).
  • 7. Das S, Medhi D, Talukdar AJ, Raja D, Sarma K, Sarma A, et al. Hepatitis C virus genotypes among population with reported risk factors in Assam, north-east India: Emergence of genotype-8. Indian Journal of Medical Research. 2024; 160 (1):43-50.
  • 8. Chakraborty A, Sarkar P, Bhaumik P. Clinical Spectrum and Genotypic Characterisation of Hepatitis-C Infection: A Cross-Sectional Study in a Teaching Hospital in Tripura International Journal of Pharmaceutical and Clinical Research. 2024; 16 (3):76-82.
  • 9. Appalaraju B, Rizwana MM. A Retrospective Study to Determine the Genotypic Distribution of Hepatitis-C from a Tertiary Care Hospital in South India. Journal of pure & applied microbiology : an international research journal of microbiology. 2023; 17 (3):1863-70.
  • 10. Thoke SV, Yadav AK. Prevalence and Genotype Distribution of Hepatitis C Virus Infection at Zonal Hospital in Northern India. Journal of Marine Medical Society. 2024; 26 (2).
  • 11. Kumar A, Mahajan H, Chaturvedi S, Kumar A, Kumar S, Sahoo GC, et al. Hepatitis C virus seroprevalence among patients enrolled at the opioid substitution therapy center in Bihar: A cross-sectional study. PLoS One. 2023; 18 (6):e0287333.
  • 12. Shalimar, Priya S, Gupta H, Bansal B, Elhence A, Krishna Kishore RV, et al. A Systematic Review of Risk Factors for Hepatitis C Virus Infection among Low-Risk Population in India. Journal of Clinical and Experimental Hepatology. 2022; 12 (6):1438-44.
  • 13. Rani V, Pavani S, Reddy PS, Srinath M. Detection of hepatitis c virus infection and its genotypic characterization among hemodialysis patients by hcv core antigen elisa and rtpcr- a hospital-based prospective study in a tertiary care hospital in south India. International Journal of Academic Medicine and Pharmacy. 2023; 5 (4):628-32.
  • 14. Khullar S, Kothari V, Khatri PK, Lohakare T. Hepatitis C Virus Seroprevalence and Genotypic Distribution Among Hemodialysis Patients at a Teaching and Training Hospital in Western Rajasthan, India. Cureus. 2024;16(8):e67175.
  • 15. Reddy A, Anitha C, Kumar LS, Ramprasad N, Ramadevi D, Trilokhya P. Hepatitis C Virus Seroprevalence and Genotypic Diversity Among Haemodialysis Patients in a District Hospital: A Comprehensive Study in Telangana, India. Pravara Med Rev. 2024;16(03):34-40.
  • 16. Shukla L, Shivaprakash P, Kumar MS. HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment. Indian Journal of Medical Research. 2023;158 (5&6):522-34.
  • 17. Solomon SS, Boon D, Saravanan S, Srikrishnan AK, Vasudevan CK, Balakrishnan P, et al. Diversity of hepatitis C virus infection among HIV-infected people who inject drugs in India. Virusdisease. 2019; 30 (4):490-7.
  • 18. Chhina D, Garg S, Chinna R. Study of Prevalence of Hepatitis B, Hepatitis C, and Other Opportunistic Co-infections in HIV-infected Patients in a Tertiary Care Hospital of North India. Journal of Gastrointestinal Infections. 2020;10 (1).
  • 19. Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: A systematic review and meta-analysis. Journal of Gastroenterology and Hepatology. 2019; 34 (2):321-9.
  • 20. Barman B, Roy A, Nune A, Lyngdoh WV, Jamil M, Tiewsoh I. Epidemiology, clinical, and laboratory profile of patients with hepatitis C: A prospective, observational study from north-eastern India. Tropical Doctor. 2022; 52 (4):484-8.
  • 21. Medhi S, Goswami B, Das AK, Singh TB, Husain SA, Sehgal A, et al. New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Archives of Virology. 2012; 157 (11):2083-93.
  • 22. Rooby EH, Peter G, Mashhood PV, John AP, Pillai YR, Premalatha N, et al. Genotype Distribution and Time Trend of Hepatitis C In South India. Journal of Clinical and Experimental Hepatology. 2014; 4: S7-S8.
  • 23. Christdas J, Sivakumar J, David J, Daniel HD, Raghuraman S, Abraham P. Genotypes of hepatitis C virus in the Indian sub-continent: a decade-long experience from a tertiary care hospital in South India. Indian Journal of Medical Microbiology. 2013;31(4):349-53.
  • 24. Shah NA, Praveen S, Kadla A, Shah A, Querishi M, Farhet S, et al. Genotype Distribution of Hepatitis C Virus in Patients With Chronic Hepatitis C Infection in Kashmir: A Cross Sectional Study. Journal of clinical and experimental Hepatology. 2016;6:S12-3.
  • 25. Gandhia P, Khushboo D, Monika P, Vaniawala S. Prevalence of HCV and Its Correlation with HCV Genotypes. European Journal of Medical and Health Sciences. 2021; 3(4):133-6.
  • 26. Yabaji PM, Shankarkumar A, Shukla A, Bhatia S. Hepatitis C virus infection in a tertiary care hospital in Mumbai, India: Identification of a mixed and novel genotype. Indian Journal of Medical Microbiology. 2018; 36 (3):352-6.
  • 27. Patil SR, Datkhile KD, Ghorpade MV, Patil SS, Kakade SV. Seroprevalence, Risk Factors and Genotype Distribution for Hepatitis C Infection: A Study from Rural Hospital in Maharashtra. Indian Journal of Medical Microbiology. 2017; 35 (4):563-7.
  • 28. Suresh P, Nair P, Magesh A, Hali RG, Roy A, Geetha RV. Seroprevalence and Genotypic Analysis of Hepatitis C Virus: Correlation with Liver Function Markers in Hemodialysis Patients International Journal of Current Pharmaceutical Review and Research. 2025;17 (3):59-68.
  • 29. Roy P, Patel A, Lole K, Gupta RM, Kumar A, Hazra S. Prevalence and genotyping pattern of hepatitis C virus among patients on maintenance hemodialysis at five centers in Pune, India. Medical Journal Armed Forces India. 2019;75 (1):74-80.
  • 30. Dutta S, Biswas A, Bakshi S, Choudhury P, Das R, Nath S, et al. Molecular Epidemiology of HCV Infection among Multi-Transfused β-Thalassemia Patients in Eastern India: A Six-Year Observation. Thalassemia Reports [Internet]. 2023; 13(3):[165-78 pp.].
  • 31. Gupta E, Samal J, Pandey A, Singh G, Gupta HAS, Agarwal R, et al. Treatment Response and Drug Resistance Profiling of Genotype 6 of Hepatitis C Virus in HCV/HIV Co-Infected Patients: A Pilot Study from INDIA. Viruses. 2022;14 (5).
  • 32. Peer NM, Joshi V, Angel A, Angel B, Chauhan VS, Buvvaji SM, et al. Characterization of Circulating HCV Genotypes: A Cohort Study in Uttar Pradesh, India. Journal of Pure and Applied Microbiology, 2024.